Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy

被引:10
作者
Shetty, Karishma [1 ]
Yasaswi, Soma [1 ]
Dutt, Shilpee [2 ,3 ]
Yadav, Khushwant S. [1 ]
机构
[1] SVKMS NMIMS Univ, Shobhaben Pratapbhai Patel Sch Pharm & Technol Ma, Mumbai, Maharashtra, India
[2] Tata Mem Hosp, Shilpee Dutt Lab, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai 410210, India
[3] Homi Bhabha Natl Inst, Training Sch Complex, Mumbai 400085, Maharashtra, India
关键词
Glioblastoma; siRNA; miRNA; Multifunctional nanocarriers; ENTRAPPED GOLD NANOPARTICLES; GENE DELIVERY; CO-DELIVERY; MOLECULAR TARGET; LUNG-CANCER; STEM-CELLS; DOXORUBICIN; RNAI; DNA; RESECTION;
D O I
10.1007/s13205-022-03365-2
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Glioblastoma multiforme (GBM) is one of the most lethal cancer due to poor diagnosis and rapid resistance developed towards the drug. Genes associated to cancer-related overexpression of proteins, enzymes, and receptors can be suppressed using an RNA silencing technique. This assists in obtaining tumour targetability, resulting in less harm caused to the surrounding healthy cells. RNA interference (RNAi) has scientific basis for providing potential therapeutic applications in improving GBM treatment. However, the therapeutic application of RNAi is challenging due to its poor permeability across blood-brain barrier (BBB). Nanobiotechnology has evolved the use of nanocarriers such as liposomes, polymeric nanoparticles, gold nanoparticles, dendrimers, quantum dots and other nanostructures in encasing the RNAi entities like siRNA and miRNA. The review highlights the role of these carriers in encasing siRNA and miRNA and promising therapy in delivering them to the glioma cells.
引用
收藏
页数:18
相关论文
共 116 条
[41]  
Khan SA, 2020, MICRO NANO TECHNOL, P1, DOI 10.1016/B978-0-12-816960-5.00001-X
[42]   EDB fibronectin and angiogenesis - A novel mechanistic pathway [J].
Khan Z.A. ;
Chan B.M. ;
Uniyal S. ;
Barbin Y.P. ;
Farhangkhoee H. ;
Chen S. ;
Chakrabarti S. .
Angiogenesis, 2005, 8 (3) :183-196
[43]   An outlook on procedures of conjugating folate to (co)polymers and drugs for effective cancer targeting [J].
Kharkar, Prashant S. ;
Soni, Govind ;
Rathod, Vaibhavi ;
Shetty, Saritha ;
Gupta, M. K. ;
Yadav, Khushwant S. .
DRUG DEVELOPMENT RESEARCH, 2020, 81 (07) :823-836
[44]   Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells [J].
Kim, Jung Seok ;
Shin, Dae Hwan ;
Kim, Jin-Seok .
JOURNAL OF CONTROLLED RELEASE, 2018, 269 :245-257
[45]   Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide [J].
Kim, Sang-Soo ;
Harford, Joe B. ;
Moghe, Manish ;
Rait, Antonina ;
Pirollo, Kathleen F. ;
Chang, Esther H. .
NUCLEIC ACIDS RESEARCH, 2018, 46 (03) :1424-1440
[46]   Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles [J].
Kong, Lingdan ;
Wu, Yilun ;
Alves, Carla S. ;
Shi, Xiangyang .
NANOMEDICINE, 2016, 11 (23) :3103-3115
[47]   Multifunctional PEI-entrapped gold nanoparticles enable efficient delivery of therapeutic siRNA into glioblastoma cells [J].
Kong, Lingdan ;
Qiu, Jieru ;
Sun, Wenjie ;
Yang, Jia ;
Shen, Mingwu ;
Wang, Lu ;
Shi, Xiangyang .
BIOMATERIALS SCIENCE, 2017, 5 (02) :258-266
[48]   Understanding the biology and advent of physics of cancer with perspicacity in current treatment therapy [J].
Korgaonkar, Nidhi ;
Yadav, Khushwant S. .
LIFE SCIENCES, 2019, 239
[49]   EGF mutant receptor vIII as a molecular target in cancer therapy [J].
Kuan, CT ;
Wikstrand, CJ ;
Bigner, DD .
ENDOCRINE-RELATED CANCER, 2001, 8 (02) :83-96
[50]   Aurora kinase B siRNA-loaded lactoferrin nanoparticles potentiate the efficacy of temozolomide in treating glioblastoma [J].
Kumari, Sonali ;
Bhattacharya, Dwaipayan ;
Rangaraj, Nandini ;
Chakarvarty, Sumana ;
Kondapi, Anand K. ;
Rao, Nalam M. .
NANOMEDICINE, 2018, 13 (20) :2579-2596